id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-282750-d9sb7o63	Benhadou, F.	Improvement of SARS‐CoV2 symptoms following Guselkumab injection in a psoriatic patient	2020-05-07		.txt	text/plain	552	12	17	Interestingly, the cytokine profile associated with SARS-CoV2 infection severity is characterised by increased levels of tumor necrosis factor , IL-1, IL-2, IL-6, IL-7, granulocyte colony stimulating factor, interferon(IFN)-γ inducible protein 10, monocyte chemoattractant protein 1, and macrophage inflammatory protein 1-α among others 4 By targeting the IL-23p19 subunit, Guselkumab does not increase the risk for viral, bacterial or fungal infections among psoriasis patients 5 . In the eye of the COVID-19 cytokine storm COVID-19: consider cytokine storm syndromes and immunosuppression Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis:	cache/cord-282750-d9sb7o63.txt	txt/cord-282750-d9sb7o63.txt
